Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Neuromodulation Market Forecast: Value Set To Climb From $8.45 Billion To $12.88 Billion
The neuromodulation market has experienced substantial growth in its size over recent years. It will grow from $7.62 billion in 2025 to $8.45 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The historical expansion can be primarily attributed to several factors including the rising prevalence of chronic pain conditions, an increasing incidence of neurological disorders, greater acceptance of minimally invasive therapies, the expansion of specialized pain management centers, and the availability of advanced implantable devices.
The neuromodulation market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $12.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.1%. The growth expected during the forecast period stems from factors such as the increasing integration of AI-assisted neuromodulation systems, a rising demand for home-based neuromodulation therapies, the broadening of indications for psychiatric and neurological disorders, a heightened focus on patient-specific stimulation protocols, and continuous technological progress in biomaterials and device miniaturization. Furthermore, major developments predicted for this period encompass a greater adoption of implantable neuromodulation devices, an increase in the use of non-invasive neuromodulation therapies, a growing incorporation of smart and programmable stimulators, the expansion of neuromodulation applications beyond pain management, and an enhanced emphasis on personalized neurotherapy.
Get A Free Sample Report With In-Depth Market Insights:
Neuromodulation Market Growth Catalysts And Demand Drivers
Anticipated increases in healthcare spending are projected to fuel the expansion of the neuromodulation market in the future. This spending encompasses the overall funds dedicated to healthcare and associated endeavors, such as delivering health services, private and public health coverage, health-related research, and public health initiatives. Elevated outlays facilitate the creation and implementation of novel treatments and diagnostic approaches for neurological conditions, with enhanced financial backing enabling greater investigation into emerging neuromodulation technologies, thereby boosting their effectiveness, security, and precision in targeting. A notable example is the total healthcare expenditure in 2023, which, as reported by the UK-based Office for National Statistics in May 2024, experienced a 5.6% rise in nominal terms, marking a 0.9% acceleration in growth compared to 2022. Consequently, the increasing healthcare expenditure is serving as a catalyst for the expansion of the neuromodulation market.
Neuromodulation Market Segment Trends And Revenue Contributors
The neuromodulation market covered in this report is segmented –
1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)
2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial
3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications
4) By End-User: Hospitals, Clinics, Home Healthcare
Subsegments:
1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems
2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)
Neuromodulation Market Trends Shaping Long-Term Demand
Leading companies in the neuromodulation market are concentrating on developing next-generation devices, such as advanced implantable pulse generators (IPGs), to enhance therapeutic precision, improve patient comfort, and maintain a competitive advantage. An IPG is a compact, battery-powered device typically implanted under the skin, often in the chest or abdomen, which delivers targeted electrical stimulation to manage neurological disorders. These innovations aim to offer greater customization, improved battery performance, and more streamlined implantation procedures. For example, in July 2023, Boston Scientific Corporation, a US-based biotechnology and biomedical engineering firm, obtained FDA approval for its Vercise Neural Navigator 5 software with STIMVIEW XT technology, designed for use with the fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System. This platform features both rechargeable and non-rechargeable IPGs and supports five MR-Conditional implantable pulse generators (IPGs), providing the broadest range of therapy options to personalize DBS therapy for individuals with Parkinson’s disease or essential tremor.
Neuromodulation Market Top Companies Driving Competitive Growth
Major companies operating in the neuromodulation market are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuros Medical Inc., Koninklijke Philips N.V., Omron Corporation
View The Full Neuromodulation Market Report:
Neuromodulation Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the neuromodulation market in 2025. The regions covered in the neuromodulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
